Live Breaking News & Updates on Health Outcome Predictive Evaluation

Stay updated with breaking news from Health outcome predictive evaluation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Cumberland Pharmaceuticals Reports First Quarter 2021 Financial Results & Company Update


Cumberland Pharmaceuticals Reports First Quarter 2021 Financial Results & Company Update
News provided by
Share this article
NASHVILLE, Tenn., May 11, 2021 /PRNewswire/  
Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company, today is providing a company update and first quarter 2021 financial results. Net revenues from continuing operations during the quarter were $10.5 million, a 26.5% increase over the prior year period. The company also recorded an additional $500,000 in revenue during the first quarter associated with divested product rights for two brands it is no longer distributing.
The Company s financial position included $93 million in total assets - with $25 million in cash, $46 million of total liabilities, and $47 million of shareholders equity at the end of the quarter. ....

United States , Cumberland Vibativ , Cumberland Vaprisol , Life Sciences Center , Health Outcome Predictive Evaluation , Cumberland Emerging Technologies Inc , Cumberland Pharmaceuticals Inc , Cumberland Pharmaceuticals , Vanderbilt University , Chief Executive Officer , Case Studies , Oral Solution , Duchenne Muscular Dystrophy , Systemic Sclerosis , Aspirin Exacerbated Respiratory Disease , Cumberland Emerging Technologies , Emerging Technologies , Sciences Center , Consolidated Statements , Net Income , Common Shareholders , Adjusted Earnings , Diluted Earnings , Adjusted Diluted Earnings , Generally Accepted Accounting Principles , Per Share ,